• Andreassi C., Zimmermann C., Mitter R., Fusco S., De Vita S., Saiardi A. and Riccio A. (2010) An NGF-responsive element targets myo-inositol monophosphatase-1 mRNA to sympathetic neuron axons. Nat. Neurosci. 13, 291301.
  • Arai R., Ito K., Ohnishi T., Ohba H., Akasaka R., Bessho Y., Hanawa-Suetsugu K., Yoshikawa T., Shirouzu M. and Yokoyama S. (2007) Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures. Proteins 67, 732742.
  • Berggard T., Szczepankiewicz O., Thulin E. and Linse S. (2002) Myo-inositol monophosphatase is an activated target of calbindin D28k. J. Biol. Chem. 277, 4195441959.
  • Berridge M. J., Downes C. P. and Hanley M. R. (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59, 411419.
  • Berry G. T., Wu S., Buccafusca R., Ren J., Gonzales L. W., Ballard P. L., Golden J. A., Stevens M. J. and Greer J. J. (2003) Loss of murine Na+/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea. J. Biol. Chem. 278, 1829718302.
  • Cryns K., Shamir A., Shapiro J. et al. (2007) Lack of lithium-like behavioral and molecular effects in IMPA2 knockout mice. Neuropsychopharmacology 32, 881891.
  • Cryns K., Shamir A., Van Acker N. et al. (2008) IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity. Neuropsychopharmacology 33, 674684.
  • Fujita S., Ohnishi T., Okuda S., Kobayashi R., Fukuno S., Furuta D., Kikuchi T., Yoshikawa T. and Fujita N. (2011) In silico study on the substrate binding manner in human myo-inositol monophosphatase 2. J. Mol. Model. 17, 25592567.
  • Kanki H., Suzuki H. and Itohara S. (2006) High-efficiency CAG-FLPe deleter mice in C57BL/6J background. Exp. Anim. 55, 137141.
  • Kimata T., Tanizawa Y., Can Y., Ikeda S., Kuhara A. and Mori I. (2012) Synaptic polarity depends on phosphatidylinositol signaling regulated by myo-inositol monophosphatase in Caenorhabditis elegans. Genetics 191, 509521.
  • Mori I. and Ohshima Y. (1995) Neural regulation of thermotaxis in Caenorhabditis elegans. Nature 376, 344348.
  • Mori I., Sasakura H. and Kuhara A. (2007) Worm thermotaxis: a model system for analyzing thermosensation and neural plasticity. Curr. Opin. Neurobiol. 17, 712719.
  • Nakayama J., Yamamoto N., Hamano K., Iwasaki N., Ohta M., Nakahara S., Matsui A., Noguchi E. and Arinami T. (2004) Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18. Neurology 63, 18031807.
  • Ogura K., Shirakawa M., Barnes T. M., Hekimi S. and Ohshima Y. (1997) The UNC-14 protein required for axonal elongation and guidance in Caenorhabditis elegans interacts with the serine/threonine kinase UNC-51. Genes Dev. 11, 18011811.
  • Ohnishi T., Ohba H., Seo K. C., Im J., Sato Y., Iwayama Y., Furuichi T., Chung S. K. and Yoshikawa T. (2007a) Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1. J. Biol. Chem. 282, 637646.
  • Ohnishi T., Yamada K., Ohba H. et al. (2007b) A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription. Neuropsychopharmacology 32, 17271737.
  • Ohnishi T., Watanabe A., Ohba H., Iwayama Y., Maekawa M. and Yoshikawa T. (2010) Behavioral analyses of transgenic mice harboring bipolar disorder candidate genes, IMPA1 and IMPA2. Neurosci. Res. 67, 8694.
  • Sjoholt G., Ebstein R. P., Lie R. T. et al. (2004) Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder. Mol. Psychiatry 9, 621629.
  • Tanizawa Y., Kuhara A., Inada H., Kodama E., Mizuno T. and Mori I. (2006) Inositol monophosphatase regulates localization of synaptic components and behavior in the mature nervous system of C. elegans. Genes Dev. 20, 32963310.
  • Watanabe A., Toyota T., Owada Y. et al. (2007) Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol. 5, e297.
  • Yoshikawa T., Turner G., Esterling L. E., Sanders A. R. and Detera-Wadleigh S. D. (1997) A novel human myo-inositol monophosphatase gene, IMP.18p, maps to a susceptibility region for bipolar disorder. Mol. Psychiatry 2, 393397.
  • Yoshikawa T., Kikuchi M., Saito K. et al. (2001) Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples. Mol. Psychiatry 6, 202210.